Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Robotic Surgery in Adult Spine Deformity

13. november 2026 oppdatert av: RadiologieSPZ

Robotic Assisted Minimal Invasive Surgery in Adult Spine Deformity

Adult spinal deformity (ASD) significantly impacts quality of life through chronic low back pain and/or spinal imbalance, impairing the ability to walk independently in patients both with and without spinal cord injury (SCI). In particular, the importance of sagittal balance of the spine and its correlation with outcome in the bipedal population are well established. Despite extensive efforts to integrate knowledge about sagittal parameters of the spine into surgical planning, there are still debates on which set of biomechanical parameters should be focused on to achieve the optimal surgical result for the individual patient.

Unique IDentifier (UniD) Adaptive Spine Intelligence (ASI, Medtronic) makes spine surgery predictable and repeatable using artificial intelligence - backed by data science. Pre-operative planning with the integration of artificial intelligence mitigates the risk of surgical and realignment failure as well as revision surgery. Once the surgical plan has been decided on, the achievement of the surgical goal is directly related to surgical performance. Here, the placement of screws into the vertebral bodies is one of the main surgical steps in ASD surgery. Thanks to technical developments, the process of screw placement has advanced from conventional X-ray-guided and/or freehand techniques to navigated and robot-assisted techniques. In particular, the safety and reproducibility of screw placement have been claimed to be superior when using robotic assistance.

In the present investigation, the primary objective is to evaluate the feasibility of software-based planning using the UniD ASI software in conjunction with robotic assistance and prebent rods during ASD surgeries with a focus on minimally invasive strategies for deformity correction. The secondary objective is to investigate both patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs). The hypothesis is that both software planning with the integration of artificial intelligence and robot-assisted minimally invasive surgeries provide a safe, reproducible, and significant improvement in clinical outcome in ASD patients.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Observasjonsmessig

Registrering (Antatt)

40

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

      • Nottwil, Sveits, 6207
        • Rekruttering
        • Swiss Paraplegic Center, Spine Surgery
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Sannsynlighetsprøve

Studiepopulasjon

The study population includes patients suffering from adult spine deformity (ASD) and who have routinely been selected to undergo deformity correction surgery with robotic and/or artificial intelligence (AI) assistence (UniD).

Beskrivelse

Inclusion Criteria:

  • Age ≥18 years
  • Patients undergoing or who have undergone surgical correction of adult spine deformity (ASD, within the cone of economy) at the Swiss Paraplegic Center (SPC) in Nottwil, Switzerland, with and without spinal cord injury (SCI)
  • Robotic and/or artificial intelligence assisted spine surgery
  • Signed general consent form

Exclusion Criteria:

  • Patients with documented pathologies impairing radiologic interpretation of data sets, e.g. active tumors affecting structural integrity of the spine, uncontrolled infections of the spine, documented congenital deformities of the spine
  • Insufficient availability of clinical and/or imaging data necessary for further investigation
  • Refusal of general consent or missing general consent form

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Adult spine deformity (ASD) patients
  • Age ≥18 years
  • Patients undergoing or who have undergone surgical correction of adult spine deformity (ASD, within the cone of economy) at the Swiss Paraplegic Center (SPC) in Nottwil, Switzerland
  • Robotic and/or artificial intelligence assisted spine surgery

Deformity correction surgery in patients suffering from adult spine deformity (ASD) according to Minimally Invasive Spinal Deformity Surgery Algorithm 2 (MISDEF-2) criteria and with the use of robotic and/or artificial intelligence (Unique IDentifier, UniD) assisted spine surgery.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Feasibility of robotic / artifical intelligence (AI)-assisted surgery
Tidsramme: From enrollment to the end of follow-up (2 years after deformity surgery).

The primary objective is to evaluate the feasibility of software-based planning using the Unique IDentifier (UniD) Adaptive Spine Intelligence (ASI, Medtronic) software in conjunction with robotic assistance and prebended rods during adult spine deformity (ASD) surgeries with a focus on minimal invasive strategies for deformity correction in patients with and without spinal cord injury (SCI).

From enrollment to the end of follow-up (2 years after deformity surgery).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Patient reported outcome measures
Tidsramme: From enrollment to the end of follow-up (2 years after deformity surgery).

The secondary objective is to investigate both patient reported outcome measures (PROMs) and patient reported experience measures (PREMs).

From enrollment to the end of follow-up (2 years after deformity surgery).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: Michael Fiechter, MD, PhD, Swiss Paraplegic Center, Spine Surgery, Nottwil, Switzerland

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

31. desember 2028

Studiet fullført (Antatt)

31. desember 2030

Datoer for studieregistrering

Først innsendt

6. november 2026

Først innsendt som oppfylte QC-kriteriene

13. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2026-00088

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

The data collected in this study are not publicly available due to restrictions under national data protection legislation. Fully anonymised data may be made available upon reasonable request, subject to approval by the local ethics committee (Ethikkommission Nordwest- und Zentralschweiz, EKNZ). The principal investigator may be contacted for guidance concerning such a data request.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .